Project Grant R35GM166438
- The National Institute of General Medical Sciences (NIGMS), part of the Department of Health and Human Services National Institutes of Health, awarded the University of Texas at Dallas $435,875 on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859, Assistance Listing) to investigate how tissue-specific progenitor cell fate is governed by mesenchymal progenitors and sympathetic neurons during adult tissue regeneration. The recipient will use the postnatal mouse...
- The National Institute of General Medical Sciences awarded the University of Texas at Dallas $431,750 on February 15, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support five-year research into the mechanisms regulating kinetics and specificity of nuclear-cytoplasmic transport. The research addresses how nuclear pore complexes (NPCs) vary in number, post-translational modifications, and protein composition across cellular and developmental contexts, and how...
- The National Institute of General Medical Sciences, part of the National Institutes of Health within the Department of Health and Human Services, awarded The University of Texas Southwestern Medical Center $488,525 on July 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859), a Project Grant (R35GM162011). The award funds evolution-guided studies of mitochondrial activities and the host response to infectious agents. The research characterizes newly identified...
- The National Institute of General Medical Sciences awarded the University of Texas at Austin $270,208 on April 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to conduct research on molecular mechanisms and developmental control of PAR polarity in animal embryos. The research resolves the network of protein-protein interactions that supports animal cell polarity and explores how this network responds to developmental signals. The work centers on an...
- The National Institute of General Medical Sciences awarded the University of Texas at Austin $429,650 on April 6, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate the interplay between cellular metabolism, chromatin regulation, and transcriptional control in ethylene signaling and stress responses in Arabidopsis. The research explores how chromatin-modifying enzymes utilize metabolic cofactors to influence histone modifications, nucleosome structure,...
- The National Institute of General Medical Sciences awarded The University of Texas Southwestern Medical Center $433,780 on April 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop innovative chemical reactions for drug discovery. The funded research pursues two research directions. First, the recipient will develop stereoselective catalytic reactions to synthesize chiral N-heterocycles—sp3-rich scaffolds prevalent in FDA-approved drugs—using...
- The National Institute of General Medical Sciences awarded the University of Texas Health Science Center at Houston $390,000 on March 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate inter-organelle unfolded protein response coordination and cellular proteostasis. The research explores how eukaryotic cells coordinate organelle-specific unfolded protein responses across mitochondria, the endoplasmic reticulum, and the cytosol to maintain...
- The National Institute of General Medical Sciences awarded The University of Texas Southwestern Medical Center $556,694 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support structural and functional analysis of ciliary complexes, with work performed in Dallas, Texas through March 31, 2031. The award funds an integrated research program combining structural cell biology, disease-focused analysis, and technical innovation to advance...
- The National Institute of General Medical Sciences awarded The University of Texas Health Science Center at San Antonio $433,125 on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support research into the spatiotemporal regulation of DNA metabolism pathways. The project examines how homologous recombination proteins are selectively activated and deactivated at DNA lesions and replication fork structures, with particular focus on tyrosine...
- The National Institute of General Medical Sciences awarded the University of Texas Health Science Center at Houston $429,000 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate the structure and function of a metabolic network coordinating membrane phospholipid homeostasis in microorganisms. The research combines quantitative biochemical and biophysical assays—including bacterial two-hybrid analysis, biolayer interferometry, crosslinking...
The National Institute of General Medical Sciences awarded the University of Texas at Dallas $1.928 million on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) for a project grant investigating how cellular metabolism shapes embryonic development. The funded research integrates advanced imaging, genetic tools, and single-cell sequencing in the chordate model Ciona to examine how metabolic rewiring orchestrates gene regulatory networks during embryogenesis. The work builds on prior findings that metabolic states in glycolysis, oxidative phosphorylation, and biomolecular chemistry are heterogeneous even within embryos at the same developmental stage. Over the five-year performance period (September 1, 2026, through August 31, 2030), the laboratory will establish multimodal measurements of metabolism at single-cell resolution to clarify the mechanistic role of metabolism in instructing developmental programs and cell fate decisions. The research capitalizes on Ciona's simplicity and evolutionary position to generate insights into conserved metabolic pathways and developmental mechanisms across chordates. Work is performed in Richardson, Texas. The funding is obligated at $1.928 million, representing a Project Grant assistance type under NIGMS's broader mission to support basic research advancing understanding of biological processes and laying the foundation for advances in disease diagnosis, treatment, and prevention.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.9m | 8/12/26 |